MBCCOP - University of Illinois at Chicago

Chicago, Illinois 60612-7323

0 studies enrolling now · 74 studies all time

What they study most

Bladder Cancer, Brain and Central Nervous System Tumors, Breast Cancer, Cancer-related Problem/Condition, Cardiac Toxicity, Cervical Cancer, Colorectal Cancer, Diarrhea, Dyspnea, Endometrial Cancer, Esophageal Cancer, Extragonadal Germ Cell Tumor

Studies at this site

• Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma — Completed
• Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia — Completed
• Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma — Completed
• FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum — Stopped early
• Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer — Stopped early
• S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma — Completed
• Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer — Stopped early
• Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer — Completed
• Docetaxel in Treating Patients With Solid Tumors — Completed
• Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer — Completed
• Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer — Completed
• Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy — Completed
• Irinotecan in Treating Aging Patients With Solid Tumors — Completed
• Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors — Stopped early
• Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy — Completed
• PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma — Completed
• Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer — Completed
• Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus — Completed
• Buspirone in Reducing Shortness of Breath in Patients With Cancer — Completed
• S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat — Stopped early
• Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients — Completed
• Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer — Completed
• S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer — Completed
• SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial — Completed
• Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer — Completed
• Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer — Stopped early
• Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women — Completed
• S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia — Completed
• S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma — Stopped early
• S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia — Completed
• S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome — Completed
• S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission — Completed
• Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer — Completed
• Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer) — Completed
• Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas — Completed
• S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer — Stopped early
• S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer — Completed
• Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer — Completed
• Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva — Completed
• Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma — Completed
• FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer — Completed
• Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy — Completed
• Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer — Completed
• Arsenic Trioxide in Treating Men With Germ Cell Cancer — Completed
• BMS-247550 in Treating Patients With Advanced Pancreatic Cancer — Completed
• Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer — Completed
• Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer — Completed
• Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer — Completed
• Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer — Completed
• Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy — Completed